Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Single Cell Open Research Endeavour (SCORE), The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Nat Immunol. 2020 Dec;21(12):1574-1584. doi: 10.1038/s41590-020-0799-x. Epub 2020 Oct 19.
A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Linc-KitSca-1Flt3 cells, termed lymphoid-primed multipotent progenitors (LMPPs), have lost megakaryocyte and erythroid potential but are heterogeneous in their fate. Here, through single-cell RNA sequencing, we identify the expression of Dach1 and associated genes in this fraction as being coexpressed with myeloid/stem genes but inversely correlated with lymphoid genes. Through generation of Dach1-GFP reporter mice, we identify a transcriptionally and functionally unique Dach1-GFP subpopulation within LMPPs with lymphoid potential with low to negligible classic myeloid potential. We term these 'lymphoid-primed progenitors' (LPPs). These findings define an early definitive branch point of lymphoid development in hematopoiesis and a means for prospective isolation of LPPs.
传统观点认为,多能造血干细胞和祖细胞(HSPCs)在特定阶段会变成谱系限制。Lin-KitSca-1Flt3 细胞,称为淋巴样前体多能祖细胞(LMPP),已经失去巨核细胞和红细胞的潜能,但在命运上存在异质性。在这里,通过单细胞 RNA 测序,我们发现这个分数中的 Dach1 和相关基因的表达与髓系/干细胞基因共同表达,但与淋巴基因呈负相关。通过 Dach1-GFP 报告基因小鼠的生成,我们在具有淋巴样潜能的 LMPP 中鉴定出一个转录和功能上独特的 Dach1-GFP 亚群,其经典的髓系潜能低至可忽略不计。我们将这些称为“淋巴样前体”(LPP)。这些发现定义了造血中淋巴发育的早期明确分支点,以及用于前瞻性分离 LPP 的方法。